IPO Boutique

Enanta Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Enanta Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Enanta PharmaceuticalsENTA -
NASDAQ
$14.00-$16.00 $14.00 $14.314 million3/21/2013
J.P. Morgan, Credit Suisse
Co-Manager(s):
Leerink Swann, JMP Securities
Health Care
Filing(s):

Filed 2012-11-06



Enanta Pharmaceuticals Quote & Chart - Click for current quote - ENTA

About Enanta Pharmaceuticals (adapted from Enanta Pharmaceuticals prospectus):
They are a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ENTA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved